| Name | Title | Contact Details |
|---|
Alignment Healthcare is redefining the business of health care by shifting the focus from payments to people. We`ve created a new model for health care delivery that cuts costs and improves lives by unraveling the inefficiencies of the current system to drive patients, providers and payers toward a common goal of wellness. Harnessing best practices from Medicare Advantage, our innovative data-management technology allows us to commit to caring for seniors and those who need it most: the chronically ill and frail. Alignment Healthcare provides partners and patients with customized care and service where they need it and when they need it, including clinical coordination, risk management and technology facilitation. Alignment Healthcare offers health plan options through Alignment Health Plan, and also partners with select health plans to help deliver better benefits at lower costs.
New London Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. New London Hospital is based in New London, NH. You can find more information on New London Hospital at www.newlondonhospital.org
Center for Bio-Medical Communication is a Hackensack, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Established in 2019 when Anne Arundel Medical Center and Doctors Community Medical Center came together to form one health system, Luminis Health is sparking a new path forward. With 595 beds across three hospitals, we currently serve seven counties in the heart of central Maryland. Our team is made up of more than 9,000 medical staff, employees and volunteers – all of whom are committed to illuminating new possibilities in health care and for our community. Thanks to them, U.S. News & World Report has deemed AAMC a top hospital in the region and the Maryland Institute for Emergency Medical Services Systems has named DCMC a primary stroke center – just to name a few accolades. We have also earned national recognition in cancer care, stroke care, innovation and patient satisfaction. We can`t wait to see what`s next.
Cellenkos is an early stage clinical biotechnology company that focuses on cord blood-derived T-regulatory cellular therapies for the treatment of autoimmune diseases and inflammatory conditions. Cellenkos is founded on the technologies arising from the laboratory investigations of Simrit Parmar, M.D. Cellenkos` lead product CK0801 delivers clinically meaningful doses of allogeneic cord blood T-regulatory cells to overcome immune dysfunction.